MAGELLAN HLTH (MGLN) Upgraded by Zacks to NEUTRAL

Zacks Investment Research upgraded shares of MAGELLAN HLTH (MGLN) from UNDERPERFORM to NEUTRAL on July 02, 2012, with a target price of $46.30.

Magellan Health Services is the country's leading behavioral managed care organization. Its customers include health plans, corporations and government agencies.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

To get a free copy of the research report on MAGELLAN HLTH (MGLN),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .